Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report

Rafael Paolo Lansang; Irene X Zhao; Perla Lansang

doi:10.1177/2050313X231180766

SAGE Open Medical Case Reports (Jun 2023)

Atopic dermatitis treated with tralokinumab and upadacitinib combination therapy: A case report

Rafael Paolo Lansang,
Irene X Zhao,
Perla Lansang

Affiliations

Rafael Paolo Lansang: Michael G. Degroote School of Medicine, McMaster University, Hamilton, ON, Canada
Irene X Zhao: Michael G. Degroote School of Medicine, McMaster University, Hamilton, ON, Canada
Perla Lansang: Division of Dermatology, University of Toronto, Toronto, ON, Canada

DOI: https://doi.org/10.1177/2050313X231180766
Journal volume & issue: Vol. 11

Abstract

Read online

A patient presented to clinic with atopic dermatitis that had been previously unresponsive to multiple topical and systemic therapies. They were successfully treated with a combination of tralokinumab and upadacitinib, showing significant improvement after 3 weeks and near-resolution after 6 months.

Published in SAGE Open Medical Case Reports

ISSN: 2050-313X (Online)
Publisher: SAGE Publishing
Country of publisher: United States
LCC subjects: Medicine: Medicine (General)
Website: https://journals.sagepub.com/home/sco

About the journal